Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001882764-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 22, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
18,054
Total Value
$278,501.98
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jun 17, 2026 | Exercise/Conversion | 6,018 | $2.48 | $14,924.64 | 57,018 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jun 17, 2026 | Sale | 1,379 | $42.78 | $59,000.51 | 55,639 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jun 17, 2026 | Sale | 3,401 | $43.86 | $149,179.42 | 52,238 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jun 17, 2026 | Sale | 1,238 | $44.75 | $55,397.41 | 51,000 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | Derivative | Jun 17, 2026 | Exercise/Conversion | 6,018 | $0.00 | $0.00 | 86,038 | Direct | โ | View Details |